STVN - Stevanato Group S.p.A.

NYSE - NYSE Delayed Price. Currency in USD

Stevanato Group S.p.A.

Via Molinella, 17
Piombino Dese, PD 35017
39 04 99 31 811

IndustryMedical Instruments & Supplies
Full Time Employees5,260

Key Executives

NameTitlePayExercisedYear Born
Mr. Franco StevanatoExec. ChairmanN/AN/A1973
Mr. Franco MoroCEO, COO & DirectorN/AN/A1963
Mr. Marco Dal LagoChief Financial OfficerN/AN/A1973
Mr. Paolo PatriChief Technology OfficerN/AN/A1970
Ms. Lisa MilesSr. VP of Investor RelationsN/AN/AN/A
Mr. Mauro StocchiChief Bus. OfficerN/AN/A1966
Mr. Riccardo ButtaPres of AmericasN/AN/A1965
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Corporate Governance

Stevanato Group S.p.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.